top of page
Spinout Evaluation & Strategy

From idea to investable opportunity.

We help evaluate spinout opportunities with structure – combining expert insight and data-driven analysis to identify those opportunities appropriate to move forward.

TAILORED SUPPORT

How we can help.

Combining structured analysis leveraging our internal platform with real-world insight, we identify opportunities that deserve investment.

11.png
Opportunity Assessment

We evaluate each disclosure’s scientific strength, development feasibility, and commercial fit – helping TTOs focus resources on the most promising inventions.

11.png
Market & Competitive Mapping

We benchmark against global innovation and competitor pipelines, providing a clear view of market potential and positioning.

11.png
Risk & Feasibility Analysis

We identify technical, regulatory and funding risks early, allowing your team to make informed investment decisions.

11.png
Comparative Attractiveness

Our internal evaluation platform standardises assessments to ensure consistency and transparency across your pipeline.

11.png
Expert Recommendations

Every assessment is reviewed by experienced spinout creators who translate findings into practical, prioritised next steps.

Expert help,
without the overhead.

50+

Assets supported.

 We've helped transition >50 candidates from the lab to the clinic.

3k+

Global investor & partner contacts.

Direct access to biotechs and investors across pharma, biotech, medtech, and animal health.

100s

Years of experience.

Small team with deep experience in drug development and spinout creation.

Or drop us a note and we’ll point you in the right direction.

bottom of page